Literature DB >> 23945375

Common and new acyclovir resistant herpes simplex virus-1 mutants causing bilateral recurrent herpetic keratitis in an immunocompetent patient.

Dongli Pan1, Stephen B Kaye, Mark Hopkins, Ruaidhri Kirwan, Ian J Hart, Donald M Coen.   

Abstract

We investigated thymidine kinase (tk) mutants isolated during multiple episodes of recurrent bilateral acyclovir resistant herpes simplex keratitis in an immunocompetent patient. From one eye, we found a single guanine insertion, previously shown to greatly reduce TK expression, and from the other, a previously unidentified substitution, which genetic experiments confirmed confers drug resistance. The substitution, although distant from substrate binding sites, reduced thymidine phosphorylation 10-20-fold, and acyclovir phosphorylation >100-fold. This phenotype should permit reactivation from latency to cause recurrent disease. The results may have implications for the prevalence and prevention of acyclovir resistance in patients with herpes simplex keratitis.

Entities:  

Keywords:  acyclovir; antiviral drug resistance; herpes simplex keratitits; herpes simplex virus; thymidine kinase

Mesh:

Substances:

Year:  2013        PMID: 23945375      PMCID: PMC3883165          DOI: 10.1093/infdis/jit437

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Aciclovir-resistant herpes keratitis.

Authors:  Keat Choong; Nathan J Walker; Andrew Jg Apel; Michael Whitby
Journal:  Clin Exp Ophthalmol       Date:  2010-04       Impact factor: 4.207

Review 2.  Herpes simplex keratitis.

Authors:  Stephen Kaye; Anshoo Choudhary
Journal:  Prog Retin Eye Res       Date:  2006-06-27       Impact factor: 21.198

3.  Low levels of herpes simplex virus thymidine- thymidylate kinase are not limiting for sensitivity to certain antiviral drugs or for latency in a mouse model.

Authors:  D M Coen; A F Irmiere; J G Jacobson; K M Kerns
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

4.  Structure to 1.9 A resolution of a complex with herpes simplex virus type-1 thymidine kinase of a novel, non-substrate inhibitor: X-ray crystallographic comparison with binding of aciclovir.

Authors:  M S Bennett; F Wien; J N Champness; T Batuwangala; T Rutherford; W C Summers; H Sun; G Wright; M R Sanderson
Journal:  FEBS Lett       Date:  1999-01-25       Impact factor: 4.124

5.  Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.

Authors:  Rui Duan; Rory D de Vries; Albert D M E Osterhaus; Lies Remeijer; Georges M G M Verjans
Journal:  J Infect Dis       Date:  2008-09-01       Impact factor: 5.226

6.  Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group.

Authors: 
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

7.  Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.

Authors:  Sonia Burrel; David Boutolleau; Georges Azar; Serge Doan; Claire Deback; Isabelle Cochereau; Henri Agut; Eric E Gabison
Journal:  J Clin Virol       Date:  2013-05-31       Impact factor: 3.168

8.  Acyclovir susceptibility and genetic characteristics of sequential herpes simplex virus type 1 corneal isolates from patients with recurrent herpetic keratitis.

Authors:  Rui Duan; Rory D de Vries; Jessica M van Dun; Freek B van Loenen; Albert D M E Osterhaus; Lies Remeijer; Georges M G M Verjans
Journal:  J Infect Dis       Date:  2009-11-01       Impact factor: 5.226

9.  High-frequency phenotypic reversion and pathogenicity of an acyclovir-resistant herpes simplex virus mutant.

Authors:  Anthony Griffiths; Donald M Coen
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 10.  Acyclovir-resistant, pathogenic herpesviruses.

Authors:  D M Coen
Journal:  Trends Microbiol       Date:  1994-12       Impact factor: 17.079

View more
  11 in total

Review 1.  Antiviral treatment and other therapeutic interventions for herpes simplex virus epithelial keratitis.

Authors:  Kirk R Wilhelmus
Journal:  Cochrane Database Syst Rev       Date:  2015-01-09

2.  Successful Management of Herpes Simplex Keratitis With Oral Valganciclovir in Patients Unresponsive or Allergic to Conventional Antiviral Therapy.

Authors:  Neslihan Dilruba Koseoglu; Benjamin R Strauss; Pedram Hamrah
Journal:  Cornea       Date:  2019-06       Impact factor: 2.651

3.  Inhibitory activity and mechanism of silver nanoparticles against herpes simplex virus type 1.

Authors:  Xuanhe Pan; Yapeng Zhang; Yiming Zhao; Siqi Yao; Chaxiang Guan; Linqian Wang; Liyu Chen
Journal:  Arch Virol       Date:  2022-06-01       Impact factor: 2.685

Review 4.  Incidence and Risk Factors of Bilateral Herpetic Keratitis: 2022 Update.

Authors:  Stergios K Chaloulis; Georgios Mousteris; Konstantinos T Tsaousis
Journal:  Trop Med Infect Dis       Date:  2022-06-07

5.  The In Vitro Replication, Spread, and Oncolytic Potential of Finnish Circulating Strains of Herpes Simplex Virus Type 1.

Authors:  Kiira Kalke; Julius Orpana; Tuomas Lasanen; Olaya Esparta; Liisa M Lund; Fanny Frejborg; Tytti Vuorinen; Henrik Paavilainen; Veijo Hukkanen
Journal:  Viruses       Date:  2022-06-13       Impact factor: 5.818

6.  Antiherpesvirus activities of two novel 4'-thiothymidine derivatives, KAY-2-41 and KAH-39-149, are dependent on viral and cellular thymidine kinases.

Authors:  Natacha Coen; Sophie Duraffour; Kazuhiro Haraguchi; Jan Balzarini; Joost J van den Oord; Robert Snoeck; Graciela Andrei
Journal:  Antimicrob Agents Chemother       Date:  2014-05-12       Impact factor: 5.191

7.  HIV integrase inhibitors block replication of alpha-, beta-, and gammaherpesviruses.

Authors:  Zhipeng Yan; Kevin F Bryant; Sean M Gregory; Magdalena Angelova; David H Dreyfus; Xue Zhi Zhao; Donald M Coen; Terrence R Burke; David M Knipe
Journal:  MBio       Date:  2014-07-01       Impact factor: 7.867

8.  Single AAV-Mediated CRISPR-SaCas9 Inhibits HSV-1 Replication by Editing ICP4 in Trigeminal Ganglion Neurons.

Authors:  Yuxi Chen; Shengyao Zhi; Puping Liang; Qi Zheng; Mengni Liu; Qi Zhao; Jian Ren; Jun Cui; Junjiu Huang; Yizhi Liu; Zhou Songyang
Journal:  Mol Ther Methods Clin Dev       Date:  2020-05-22       Impact factor: 6.698

9.  Antiviral Potential of Sea Urchin Aminated Spinochromes against Herpes Simplex Virus Type 1.

Authors:  Natalia P Mishchenko; Natalia V Krylova; Olga V Iunikhina; Elena A Vasileva; Galina N Likhatskaya; Evgeny A Pislyagin; Darya V Tarbeeva; Pavel S Dmitrenok; Sergey A Fedoreyev
Journal:  Mar Drugs       Date:  2020-11-05       Impact factor: 5.118

Review 10.  New strategies against drug resistance to herpes simplex virus.

Authors:  Yu-Chen Jiang; Hui Feng; Yu-Chun Lin; Xiu-Rong Guo
Journal:  Int J Oral Sci       Date:  2016-03-30       Impact factor: 6.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.